SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AB4. A total of 2 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $203,000 | +37.2% | 25,000 | 0.0% | 0.00% | – |
| Q1 2017 | $148,000 | +24.4% | 25,000 | 0.0% | 0.00% | – |
| Q4 2016 | $119,000 | +1.7% | 25,000 | 0.0% | 0.00% | – |
| Q3 2016 | $117,000 | +21.9% | 25,000 | 0.0% | 0.00% | – |
| Q2 2016 | $96,000 | +33.3% | 25,000 | 0.0% | 0.00% | – |
| Q1 2016 | $72,000 | +14.3% | 25,000 | 0.0% | 0.00% | – |
| Q4 2015 | $63,000 | -4.5% | 25,000 | 0.0% | 0.00% | – |
| Q3 2015 | $66,000 | -17.5% | 25,000 | 0.0% | 0.00% | – |
| Q2 2015 | $80,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 25,000 | $203,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 50,000 | $407,000 | 0.00% |